U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07713758) titled 'A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function' on July 15.
Brief Summary: This trial is intended to understand how the body processes repinatrabit in people with moderate liver impairment and severe kidney impairment and also to compare these results with people of similar age, weight, and sex who have normal liver function.
Study Start Date: July 17
Study Type: INTERVENTIONAL
Condition:
Phenylketonuria
Intervention:
DRUG: Repinatrabit
Oral tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Otsuka Pharm...